Aesculap AG
The goal of this interventional post-market follow-up study is to evaluate radiological changes in the diaphyseal bone density (Gruen Zones 3 and 4) within 24 months postoperative in patients treated with CoreHip® primary cementless stem. The DEXA bone density analysis is used.
Primary Osteoarthritis
Cartilage Degeneration
Osteoarthritis, Hip
Inflammatory Arthritis
Osteonecrosis of Femoral Head
Traumatic Disorder
Primary hip replacement with cementless stem
NA
Additional diagnostic examination: DEXA-Analysis. A DEXA scan is an imaging test that measures bone density (strength). The results can provide helpful details about risk for osteoporosis (bone loss) and fractures. Furthermore we would like to find out more about stress shielding processes around our prosthesis.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 40 participants |
Masking : | NONE |
Primary Purpose : | DIAGNOSTIC |
Official Title : | DEXA Bone Density Analysis to Analyze the Loading Concept of the CoreHip® Prosthesis |
Actual Study Start Date : | 2025-06 |
Estimated Primary Completion Date : | 2025-12 |
Estimated Study Completion Date : | 2026-05 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 35 Years to 85 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Medical University of Hanover
Hannover, Germany, 30625